Literature DB >> 12804862

CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum.

Yan Zhang1, Guy H Palmer, Jeffrey R Abbott, Chris J Howard, Jayne C Hope, Wendy C Brown.   

Abstract

Immunostimulatory oligodeoxynucleotides containing unmethylated CpG dinucleotides (CpG ODN) stimulate IL-12-dependent Th1 dominated cytokine and enhanced IgG responses when co-delivered with antigen to mice. However, the CpG ODN sequences that are optimal for each mammalian species may differ. Previously, we demonstrated that a CpG ODN containing the GTCGTT motif was optimal for stimulating bovine B cell proliferation, and induced IL-6, IL-12 and IFN-gamma production by peripheral blood mononuclear cells (PBMC). The current study was designed to test the hypothesis that the nuclease resistant phosphorothioate modified ODN 2006 (TCGTCGTTTTGTCGTTTTGTCGTT) would induce antigen-specific type 1 cytokine and enhanced IgG responses similar to those induced by IL-12. To test this adjuvant effect, calves were immunized with Anaplasma marginale major surface protein 2 (MSP2) with alum alone or combined with CpG ODN 2006, non-CpG ODN R2006 or IL-12. MSP2-specific IgG1 and IgG2 responses developed more rapidly in calves given IL-12, ODN 2006 or ODN R2006, but the highest IgG1 titers were obtained in CpG ODN-immunized calves. Antigen-specific lymphocyte proliferation and frequency of IFN-gamma-secreting cells were significantly increased in CpG ODN 2006- or IL-12-treated calves, and antigen-stimulated PBMC from these calves also expressed higher levels of IFN-gamma transcripts and lower levels of IL-4 transcripts. No differences in IL-10 mRNA expression were detected among the groups. These results indicate that CpG ODN 2006 is an effective vaccine adjuvant for stimulating both antibody and IFN-gamma mediated cellular immune responses in cattle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804862     DOI: 10.1016/s0264-410x(03)00176-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.

Authors:  Junzo Norimine; Juan Mosqueda; Guy H Palmer; Harris A Lewin; Wendy C Brown
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.

Authors:  J C Hope; M L Thom; M McAulay; E Mead; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

4.  Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.

Authors:  Lauren M Staska; Christopher J Davies; Wendy C Brown; Travis C McGuire; Carlos E Suarez; Joo Youn Park; Bruce A Mathison; Jeffrey R Abbott; Timothy V Baszler
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.

Authors:  M L Thom; M McAulay; H M Vordermeier; D Clifford; R G Hewinson; B Villarreal-Ramos; J C Hope
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

6.  Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.

Authors:  Junzo Norimine; Sushan Han; Wendy C Brown
Journal:  Immunogenetics       Date:  2006-08-19       Impact factor: 2.846

7.  Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.

Authors:  J C Hope; M L Thom; B Villarreal-Ramos; H M Vordermeier; R G Hewinson; C J Howard
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

8.  Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.

Authors:  Job E Lopez; Guy H Palmer; Kelly A Brayton; Michael J Dark; Stephanie E Leach; Wendy C Brown
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

9.  Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge.

Authors:  Junzo Norimine; Juan Mosqueda; Carlos Suarez; Guy H Palmer; Terry F McElwain; Gabriel Mbassa; Wendy C Brown
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.

Authors:  Maximiliano J Jiménez-Dalmaroni; Catherine M Radcliffe; David J Harvey; Mark R Wormald; Petra Verdino; Gary D Ainge; David S Larsen; Gavin F Painter; Richard Ulevitch; Bruce Beutler; Pauline M Rudd; Raymond A Dwek; Ian A Wilson
Journal:  Innate Immun       Date:  2014-03-03       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.